Oncotarget

Corrections:

Correction: Kinetic change of serum carcinoembryonic antigen can early predict progression in patients with metastatic non-small cell lung cancer during maintenance therapy with bevacizumab plus pemetrexed

PDF  |  How to cite

Oncotarget. 2017; 8:110732-110732. https://doi.org/10.18632/oncotarget.23291

Metrics: PDF 678 views  |   ?  

Nasha Zhang1,2, Li Kong2,3, Fang Shi2,3, Wang Jing2, Haiyong Wang2,3, Ming Yang2,3, Jinming Yu2,3 and Hui Zhu2,3

1 Cheeloo College of Medicine, Shandong University, Jinan, China
2 Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong Cancer Hospital Affliated to Shandong University, Jinan, China
3 Shandong Academy of Medical Sciences, Jinan, China

Published: December 15, 2017

This article has been corrected: the authors first and last names order was updated

Original article: Oncotarget. 2017; 8:74910-74916. DOI: https://doi.org/10.18632/oncotarget.20456.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 23291